Retinoblastoma cost-effectiveness of therapy

Revision as of 15:23, 27 November 2017 by Mmir (talk | contribs) (Mahshid)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma cost-effectiveness of therapy

CDC on Retinoblastoma cost-effectiveness of therapy

Retinoblastoma cost-effectiveness of therapy in the news

Blogs on Retinoblastoma cost-effectiveness of therapy

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS

Template:Nervous tissue tumors